
Founded in 2013, Aakaar Medical Technologies Limited is a medical aesthetic company specialising in cosmetic products and devices, including the skin and hair care range, injectables, contouring and other products through exclusive B2B channels. The company serves dermatologists, plastic surgeons, and aesthetic physicians. The company operates via two revenue streams: its own brands and imported brands from Korea, Spain, Italy, and Austria. In FY25, 37.53% of the revenue came from own brands, while the rest (62.47%) came from imported brands. The company expanded its SKU portfolio from 121 to 154 between FY23 and FY25, focusing on higher-margin aesthetic products while maintaining steady device business.
Bidding starts for all investor categories
Last day to place your bid
Share allotment finalised
Refunds credited for non-allottees
Allotted shares credited to demat account
Shares list on NSE / BSE
Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.
| Investor Type | Min Lots | Min Shares | Min Amount | Max Lots | Max Amount | Notes |
|---|---|---|---|---|---|---|
| Retail / Individual | 1 | 1600 | ₹115,200 | 1 | ₹115,200 | 1 lot only |
| HNI | 2 | 3200 | ₹230,400 | 2 | ₹230,400 | Min 2 lots |
| Category | Reservation | Shares Offered | Amount (₹ Cr) | Shares Bid | Subscribed | Allotment % |
|---|---|---|---|---|---|---|
| QIB | 50% | 1,928,572 | 13.5 | 0 | 0.00x | 100% |
| NII | 15% | 578,571 | 4.05 | 0 | 0.00x | 100% |
| Retail | 35% | 1,350,000 | 9.45 | 0 | 0.00x | 100% |
Retail is a lottery-based allotment when oversubscribed; QIB/NII get pro-rata. Probability ≈ 1 / subscription times (100% if under-subscribed).